EUVIMEDEUVIMED entdecken
Crossref

EFFICACY AND SAFETY OF A FIXED-DOSE COMBINATION OF CHLORZOXAZONE, DICLOFENAC POTASSIUM, AND PARACETAMOL COMPARED WITH DICLOFENAC POTASSIUM AND PARACETAMOL IN ACUTE MUSCULOSKELETAL SPASM: A MULTICENTER RANDOMIZED PHASE IV STUDY

Ashutosh Aggarwal, Samir Grover, Harshil Kansara, Anil Bhargava, Hrishikesh Patkar, Abhimanyu Madhual

International Journal of Medicine and Public Healt · 2026-06 · 16 (2) · 2086-2094

DOI: 10.70034/ijmedph.2026.2.349 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Medicine and Public Healt, 2026-06. Verfasst von Ashutosh Aggarwal und 5 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Acute musculoskeletal spasm is a common clinical condition associated with pain, stiffness, and functional impairment, significantly affecting quality of life and daily activities. Conventional treatment with nonsteroidal anti-inflammatory drugs (NSAIDs) and paracetamol may not adequately address the underlying muscle spasm conditions, highlighting the need for multimodal therapeutic approaches. The objective is to evaluate the efficacy and safety of a fixed-dose combination of chlorzoxazone, diclofenac potassium, and paracetamol compared with diclofenac potassium and paracetamol in patients with acute musculoskeletal spasm. Materials and Methods: This Phase IV, prospective, randomized, open label, multicentric comparative study enrolled 200 patients across five centres. Patients were randomized (1:1) to receive either chlorzoxazone 500 mg + diclofenac potassium 50 mg + paracetamol 325 mg or diclofenac potassium 50 mg + paracetamol 325 mg, administered orally twice daily for 5 days. Primary efficacy endpoints included changes in pain intensity at rest and during passive movement using the Numeric Rating Scale (NRS), muscle spasm score, and global assessments by patients and physicians. Safety was evaluated through monitoring of adverse events.

Results

Of the 200 patients enrolled, 196 completed the study. By Day 5, significantly more patients in the FDC group achieved complete pain relief at rest (62.89% vs. 25.25%) and during movement (52.58% vs. 15.15%) compared to the comparator group (p < 0.001). Complete resolution of muscle spasm was higher in the FDC group (74.23% vs. 38.38%; p < 0.001). Global assessments favored the FDC (p < 0.01). Adverse events were low and comparable, with no serious events.

Conclusion

The chlorzoxazone-based FDC demonstrated superior efficacy with comparable safety, providing an effective option for acute musculoskeletal spasm. Keywords: Acute musculoskeletal spasm; Chlorzoxazone; Diclofenac potassium; Paracetamol; Randomized clinical trial; Muscle relaxants.

Zitieren

APA

Aggarwal, A., Grover, S., Kansara, H., Bhargava, A., Patkar, H., & Madhual, A. (2026). EFFICACY AND SAFETY OF A FIXED-DOSE COMBINATION OF CHLORZOXAZONE, DICLOFENAC POTASSIUM, AND PARACETAMOL COMPARED WITH DICLOFENAC POTASSIUM AND PARACETAMOL IN ACUTE MUSCULOSKELETAL SPASM: A MULTICENTER RANDOMIZED PHASE IV STUDY. International Journal of Medicine and Public Healt, 16(2), 2086-2094. https://doi.org/10.70034/ijmedph.2026.2.349

Vancouver

Aggarwal A, Grover S, Kansara H, Bhargava A, Patkar H, Madhual A. EFFICACY AND SAFETY OF A FIXED-DOSE COMBINATION OF CHLORZOXAZONE, DICLOFENAC POTASSIUM, AND PARACETAMOL COMPARED WITH DICLOFENAC POTASSIUM AND PARACETAMOL IN ACUTE MUSCULOSKELETAL SPASM: A MULTICENTER RANDOMIZED PHASE IV STUDY. International Journal of Medicine and Public Healt. 2026;16(2):2086-2094. doi:10.70034/ijmedph.2026.2.349

BibTeX
@article{Aggarwal2026,
  author = {Aggarwal, Ashutosh and Grover, Samir and Kansara, Harshil and Bhargava, Anil and Patkar, Hrishikesh and Madhual, Abhimanyu},
  title = {EFFICACY AND SAFETY OF A FIXED-DOSE COMBINATION OF CHLORZOXAZONE, DICLOFENAC POTASSIUM, AND PARACETAMOL COMPARED WITH DICLOFENAC POTASSIUM AND PARACETAMOL IN ACUTE MUSCULOSKELETAL SPASM: A MULTICENTER RANDOMIZED PHASE IV STUDY},
  journal = {International Journal of Medicine and Public Healt},
  year = {2026},
  volume = {16},
  number = {2},
  pages = {2086--2094},
  doi = {10.70034/ijmedph.2026.2.349}
}
Kostenlos starten →